The Lancet Diabetes & Endocrinology

The Lancet Diabetes & Endocrinology - ISSN 2213-8587
Source Normalized Impact per Paper (SNIP): 5.917 Source Normalized Impact per Paper (SNIP):
SNIP measures contextual citation impact by weighting citations based on the total number of citations in a subject field.
SCImago Journal Rank (SJR): 10.088 SCImago Journal Rank (SJR):
SJR is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and a qualitative measure of the journal’s impact.
Impact Factor: 24.54 (2018) Impact Factor:
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© 2017 Journal Citation Reports ® (Clarivate Analytics, 2017)
5 Year Impact Factor: 23.013 (2018) Five-Year Impact Factor:
To calculate the five year Impact Factor, citations are counted in 2016 to the previous five years and divided by the source items published in the previous five years.
© 2017 Journal Citation Reports ® (Clarivate Analytics, 2017)
Volumes: Volume 8
Issues: 12 issues
ISSN: 22138587
Editor-in-Chief: Davies

Institutional Subscription

eJournal
This journal does not feature personal pricing and is not available for personal subscription.

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

The Lancet Diabetes & Endocrinology is dedicated to providing a global, authoritative, and independent forum for high impact clinical research and opinion covering all aspects of endocrinology, diabetes, metabolism, obesity, osteoporosis, bone metabolism, as well as thyroid, lipid, and adrenal disorders. Continuing in The Lancet's tradition of publishing high-impact content that influences medical practice, the journal delivers essential research, expert review, and candid commentary to provide context and perspective on important advances shaping these fields today.



The Lancet Diabetes & Endocrinology is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Original Research is fast-tracked to publication within 8 weeks on average of submission and published Online First on www.thelancet.com before appearing in print.



Now indexed in PubMed, Journal Citation Reports®, and Scopus, the journal accepts submissions of Original Research, Review, and Personal Views. Visit http://ees.elsevier.com/thelancetde to learn more about our editorial scope and aims and to submit your manuscript.



Gold or Green Open Access is available for research supported by selected funding agencies with whom Elsevier has an agreement. The journal is also freely available to readers in low-to-middle-income countries via the HINARI programme or via IP access at www.thelancet.com.



To find out more about The Lancet Diabetes & Endocrinology, visit www.thelancet.com/diabetes-endocrinology.